IDT Biologika is a Germany-based biologics CDMO and a global leader in vaccines and viral vector contract manufacturing, with years of experience in development and manufacture of live viral vaccines, viral vectors, and immunotherapeutic agents. The company offers clients a broad range of technology platforms and GMP-compliant, end-to-end services, overseeing product development from clinical stages through commercial production. With locations in Germany and the U.S., IDT Biologika has successfully fostered partnerships with multinational pharmaceutical and biotech companies worldwide.
